A detailed history of Richard P Slaughter Associates Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Richard P Slaughter Associates Inc holds 995 shares of LLY stock, worth $858,545. This represents 0.22% of its overall portfolio holdings.

Number of Shares
995
Previous 2,165 54.04%
Holding current value
$858,545
Previous $1.69 Million 55.01%
% of portfolio
0.22%
Previous 0.46%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 09, 2025

SELL
$625.65 - $812.69 $732,010 - $950,847
-1,170 Reduced 54.04%
995 $759,000
Q2 2025

Jul 08, 2025

BUY
$713.71 - $898.95 $114,193 - $143,832
160 Added 7.98%
2,165 $1.69 Million
Q1 2025

Apr 10, 2025

BUY
$725.72 - $929.72 $1.46 Million - $1.86 Million
2,005 New
2,005 $1.66 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $820B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Richard P Slaughter Associates Inc Portfolio

Follow Richard P Slaughter Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richard P Slaughter Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Richard P Slaughter Associates Inc with notifications on news.